Physician Board Certification

ABPath Blood Banking / Transfusion Medicine Subspecialty Certification Examination Practice Test

Blood banking and transfusion medicine combines immunohematology with decisions about blood components, compatibility, and transfusion safety. Practice topics include red-cell antibody interpretation, pretransfusion testing, plasma selection and modification, transfusion-reaction investigation, and management of complications such as citrate toxicity. The cases connect laboratory findings to time-sensitive choices in patient care.

Exam overview

Exam providerAmerican Board of Pathology
Exam codeNot listed
CategoryPhysician Board Certification

About the ABPath Blood Banking / Transfusion Medicine Subspecialty Certifica… Exam

Questions can build reasoning across the transfusion process: selecting a compatible red-cell unit, interpreting antibody reactivity by temperature and testing phase, and recognizing when an antibody affects component choice. Scenarios also address component use, including plasma selection and strategies to reduce allergic reactions, as well as urgent response to suspected hemolysis or bacterial contamination. Other cases involve fetomaternal hemorrhage screening and citrate-related symptoms during therapeutic plasma exchange. For each problem, identify the clinical risk, determine which laboratory finding or compatibility test resolves it, and choose an action that protects the patient while preserving needed treatment. These tasks reflect the collaboration between transfusion services and clinical teams when evaluating requests, issuing components, and investigating adverse events.

Sample Practice Questions

Review a selection from this exam's published US Practice Tests practice bank.

Question 1

A patient is being evaluated for fetomaternal hemorrhage after delivery. Which fetal red-cell characteristic is used in the rosette screening test in an RhD-negative mother?

  1. APresence of the RhD antigen on fetal red cells
  2. BPresence of the Kell antigen on fetal red cells
  3. CAbsence of the H antigen on fetal red cells
  4. DExpression of adult hemoglobin in fetal red cells
Show answerCorrect answer: A

The rosette test is a qualitative screen based on detection of RhD-positive fetal red cells in an RhD-negative maternal circulation. A positive screen is generally followed by a quantitative method to estimate the fetomaternal hemorrhage when needed.

Question 2

Which plasma component is generally preferred for a patient with group O blood when plasma transfusion is needed?

  1. AGroup A plasma
  2. BGroup B plasma
  3. CGroup O plasma
  4. DGroup AB plasma
Show answerCorrect answer: D

Group AB plasma contains neither anti-A nor anti-B and is broadly compatible with recipients of any ABO group. Group O plasma contains both anti-A and anti-B, which can hemolyze a non-O recipient's red cells.

Question 3

A patient with a history of pregnancy has a positive screen for an antibody reactive at room temperature that is identified as anti-Leᵃ. The antibody is not reactive at 37°C or in the antiglobulin phase, and there is no history of hemolytic transfusion reaction. What is generally appropriate for red-cell selection?

  1. ASelect units negative for the Lewisᵃ antigen in every case
  2. BUse units compatible by the antiglobulin crossmatch
  3. CUse only group O red cells
  4. DUse washed red cells because Lewis antibodies are plasma proteins
Show answerCorrect answer: B

Lewis antibodies are often naturally occurring and usually do not cause clinically significant hemolysis when they are not reactive at 37°C or in the antiglobulin phase. Red cells compatible by an appropriate crossmatch are generally suitable; antigen-negative units are not routinely required in this circumstance.

Question 4

A patient with a history of severe allergic reactions to plasma proteins requires a plasma-containing component. Which modification is most appropriate to reduce the risk of recurrent allergic reactions?

  1. AIrradiation
  2. BWashing
  3. CPathogen reduction
  4. DVolume reduction
Show answerCorrect answer: B

Washing removes most residual plasma proteins from cellular components, which can reduce recurrent allergic reactions in selected patients with severe or recurrent reactions. It does not replace evaluation and appropriate management of the prior reaction.

Question 5

A patient develops fever and rigors during platelet transfusion. The clerical check is correct, and the patient is stable after the transfusion is stopped. Which laboratory finding most strongly supports bacterial contamination of the platelet component?

  1. APositive culture of the residual component with the same organism recovered from the patient
  2. BA newly detected red-cell alloantibody in the patient's plasma
  3. CA positive acid elution test for fetal hemoglobin
  4. DAn increased serum haptoglobin concentration
Show answerCorrect answer: A

Recovery of the same organism from the residual component and the patient strongly supports transfusion-transmitted bacterial infection. Febrile reactions require prompt assessment; component and patient cultures should be obtained when contamination is suspected.

Question 6

A patient with a mechanical heart valve takes warfarin and presents with major bleeding. The INR is markedly elevated, and rapid reversal is required. Which plasma-derived product provides concentrated vitamin K-dependent coagulation factors with relatively low volume?

  1. ACryoprecipitate
  2. BFour-factor prothrombin complex concentrate
  3. CAlbumin
  4. DFibrinogen concentrate
Show answerCorrect answer: B

Four-factor prothrombin complex concentrate contains factors II, VII, IX, and X and is used for rapid reversal of vitamin K antagonist anticoagulation, generally together with vitamin K. It delivers these factors in much less volume than plasma.

Question 7

During a therapeutic plasma exchange for a neurologic disorder, a patient develops perioral tingling while citrate-anticoagulated plasma is being processed. Which intervention most directly addresses the likely cause?

  1. AAdminister calcium according to the treatment protocol and assess symptoms
  2. BGive additional citrate anticoagulant
  3. CReplace the exchange fluid with packed red cells only
  4. DAdminister vitamin K
Show answerCorrect answer: A

Citrate binds ionized calcium and can cause symptomatic hypocalcemia during apheresis procedures. Calcium replacement and monitoring, guided by the procedure protocol and clinical status, address the underlying mechanism.

How to use this practice test

Access is free. A session presents up to 20 random questions from the 50-question practice bank, with results shown after completion. Use each case to test component selection, compatibility reasoning, reaction recognition, and the interpretation of transfusion-medicine laboratory findings; revisit missed items by identifying the clinical clue that should guide the decision.

Preparation tips

  • For antibody cases, distinguish room-temperature reactivity from 37°C and antiglobulin-phase reactivity, then relate the pattern to red-cell selection and clinical significance.
  • Practice the immediate response to suspected acute hemolysis: stop the transfusion, assess the patient, and connect specimen findings with the reaction investigation.
  • Compare plasma and plasma-derived products by clinical purpose, compatibility considerations, factor content, and volume; distinguish routine selection from urgent reversal needs.
  • Review how the rosette screen detects fetal red cells in an RhD-negative maternal sample, and connect citrate symptoms during plasma exchange with calcium management.
  • For platelet-reaction scenarios, separate febrile reactions from possible bacterial contamination and identify the component and patient findings that warrant investigation.
Official sourceOfficial exam page ↗Official exam guide ↗